Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.08 -0.17 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Interest & Investment Income (2020 - 2026)

Updated

Xeris Biopharma Holdings' Interest & Investment Income was $1.46 million in Q2 2026, up 53.5% from $948,000 a year earlier and up 21.0% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Interest & Investment Income (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Xeris Biopharma Holdings' Interest & Investment Income was $5.28 million through Jun 30, 2026, up 24.7% year-over-year; for FY2025, it was $4.74 million, down 10.9% from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $5.32 million in FY2024 (+12.0%), $4.75 million in FY2023 (+84.3%), $2.58 million in FY2022 (+723.6%) and $313,000 in FY2021 (-89.4%).
  • Quarterly Interest & Investment Income has moved between $66,000 (Q3 2021) and $1.92 million (Q1 2024) over five years.
  • Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 4.6% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q3 2022 (growth of 615.2%); the worst was Q4 2021 (a decline of 96.5%).
  • Per Business Quant data, XERS's Interest & Investment Income in the three quarters before Q2 2026 was $1.2 million (Q1 2026), $1.46 million (Q4 2025) and $1.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Xeris Biopharma Holdings 1.58 Bn 1.14 Bn 79.59 Mn 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.46 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 948,000.00
Mar 31, 2025 1.18 Mn
Dec 31, 2024 910,000.00
Sep 30, 2024 1.20 Mn
Jun 30, 2024 1.29 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.84 Mn
Sep 30, 2022 472,000.00
Jun 30, 2022 195,000.00
Mar 31, 2022 68,000.00
Dec 31, 2021 70,000.00
Sep 30, 2021 66,000.00
API Access

Xeris Biopharma Holdings Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=XERS&period=max&api_key=YOUR_API_KEY